Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Esophageal Distensibility and Mucosal Impedance in Dysplastic Barrett's Esophagus Patients Undergoing Radiofrequency Ablation

NCT07126535 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07126535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07126535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Esophageal Distensibility and Mucosal Impedance in Dysplastic Barrett's Esophagus Patients Undergoing Radiofrequency Ablation
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
August 19, 2025
Completion date
July 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, dysplastic barrett's esophagus, radiofrequency ablation